COVID-associated non-vasculitic thrombotic retiform purpura of the face and extremities: A case report

Authors

Connor M. Bunch, Henry Ford HealthFollow
Nuha Zackariya
Anthony V. Thomas
Jack H. Langford
Michael Aboukhaled
Samuel J. Thomas
Aida Ansari
Shivani S. Patel
Hallie Buckner
Joseph B. Miller MD, Henry Ford HealthFollow
Christy L. Annis
Margaret A. Quate-Operacz
Leslie A. Schmitz
Joseph J. Pulvirenti
Jonathan C. Konopinski
Kathleen M. Kelley
Samer Hassna
Luke G. Nelligan
Mark M. Walsh

Recommended Citation

Bunch CM, Zackariya N, Thomas AV, Langford JH, Aboukhaled M, Thomas SJ, Ansari A, Patel SS, Buckner H, Miller JB, Annis CL, Quate-Operacz MA, Schmitz LA, Pulvirenti JJ, Konopinski JC, Kelley KM, Hassna S, Nelligan LG, and Walsh MM. COVID-associated non-vasculitic thrombotic retiform purpura of the face and extremities: A case report. Clin Case Rep 2022; 10(12):e6790.

Document Type

Article

Publication Date

12-1-2022

Publication Title

Clin Case Rep

Abstract

SARS-CoV-2 infection can manifest many rashes. However, thrombotic retiform purpura rarely occurs during COVID-19 illness. Aggressive anti-COVID-19 therapy with a high-dose steroid regimen led to rapid recovery. This immunothrombotic phenomenon likely represents a poor type 1 interferon response and complement activation on the endothelial surface in response to acute infection.

PubMed ID

36590660

Volume

10

Issue

12

First Page

6790

Last Page

6790